Summary

Exosome Research Market Trends and Forecast
The future of the global exosome research market looks promising with opportunities in the academic & research institute, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratory markets. The global exosome research market is expected to reach an estimated $1.16 billion by 2028 with a CAGR of 33.6% from 2023 to 2028. The major drivers for this market are increasing number of cancer patients, growing need for cell-free therapies to treat variety of diseases, and rising funds for life sciences research.

Exosome Research Market by Segment
The study includes a forecast for the global exosome research market by product & service, indication, application, end use, and region, as follows:
Exosome Research Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:
• Kits & Reagents
• Instruments
• Services
Exosome Research Market by Indication [Value ($B) Shipment Analysis from 2017 to 2028]:
• Cancer
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others
Exosome Research Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
• Biomarkers
• Vaccine Development
• Tissue Regeneration
• Others
Exosome Research Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospital & Clinical Testing Laboratories
Exosome Research Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Exosome Research Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome research companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome research companies profiled in this report include.
• Thermo Fisher Scientific
• Bio-Techne Corporation
• QIAGEN
• System Biosciences
• Miltenyi Biotec
• NanoSomiX
• NorgenBiotek Corp.
• AMS Biotechnology
• Lonza

Exosome Research Market Insights
• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period because it helps in eliminating the tedious process of isolation of extracellular vesicles.
• Within this market, academic & research institutes are expected to remain the largest segment due to their capability of disease diagnosis and emerging role as an intercellular messengers, has resulted in an increase in demand for exosome study in recent years.
• North America is expected to remain the largest segment during the forecast period due to favorable government support in the form of funding for bio sciences research and presence of advanced infrastructure for diagnostic and lab research in the region.

Features of the Exosome Research Market
• Market Size Estimates: Exosome research market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Exosome research market size by various segments, such as by product & service, indication, application, end use, and region
• Regional Analysis: Exosome research market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by product & service, indication, application, end use, and regions for the exosome research market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the exosome research market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ
Q1. What is the exosome research market size?
Answer: The global exosome research market is expected to reach an estimated $1.16 billion by 2028.
Q2. What is the growth forecast for exosome research market?
Answer: The global exosome research market is expected to grow with a CAGR of 33.6% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the exosome research market?
Answer: The major drivers for this market are increasing number of cancer patients, growing need for cell-free therapies to treat variety of diseases, and rising funds for life sciences research.
Q4. What are the major segments for exosome research market?
Answer: The future of the exosome research market looks promising with opportunities in the academic & research institute, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratory markets.
Q5. Who are the key exosome research companies?
Answer: Some of the key exosome research companies are as follows:
• Thermo Fisher Scientific
• Bio-Techne Corporation
• QIAGEN
• System Biosciences
• Miltenyi Biotec
• NanoSomiX
• NorgenBiotek Corp.
• AMS Biotechnology
• Lonza
Q6. Which exosome research segment will be the largest in future?
Answer:Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period because it helps in eliminating the tedious process of isolation of extracellular vesicles.
Q7. In exosome research market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest segment during the forecast period due to favourable government support in the form of funding for bio sciences research and presence of advanced infrastructure for diagnostic and lab research in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the exosome research market by product & service (kits & reagents, instruments, and services), indication (cancer, neurodegenerative diseases, cardiovascular disease, infectious diseases, and others), application (biomarkers, vaccine development, tissue regenerative, and others), end use industry (academic & research institutes, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

ページTOPに戻る

Table of Contents